OTC人工涙液の世界市場2021年-2028年:製品種類別(溶液、軟膏、乳剤、ゲル、スプレー溶液、懸濁液)、容器種類別、製剤別、用途別、流通チャネル別

◆英語タイトル:OTC Artificial Tears Market by Product Type (Solution, Ointment, Emulsion, Gel, Spray Solution, and Suspensions), Container Type (Plastic Single Dose Container, Plastic Multi-Dose Container, and Spray), Formulation (Preservative Based and Non-Preservative Based), Application (Dry Eye Syndrome, Allergies, Infections, UV and Blue Light Protection, Contact Lens Moisture Retention, and Others), and Distribution Channel (Hospital Pharmacies, Drug Stores, and Retail Pharmacies & Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021––2028
◆商品コード:AMR21JU074
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2021年5月31日
◆ページ数:376
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD6,168 ⇒換算¥678,480見積依頼/購入/質問フォーム
5 UserUSD6,929 ⇒換算¥762,190見積依頼/購入/質問フォーム
Enterprise UserUSD9,663 ⇒換算¥1,062,930見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、OTC人工涙液の世界市場について調査し、イントロダクション、エグゼクティブサマリー、市場状況、製品種類別(溶液、軟膏、乳剤、ゲル、スプレー溶液)分析、容器種類別(プラスチック製単回投与容器、プラスチック製複数回投与容器、スプレー)分析、製剤別(防腐剤、非防腐剤)分析、用途別(ドライアイ症候群、アレルギー、感染症、紫外線・ブルーライト保護、コンタクトレンズ水分保持)分析、地域別分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場状況
・OTC人工涙液の世界市場規模:製品種類別(溶液、軟膏、乳剤、ゲル、スプレー溶液)
・OTC人工涙液の世界市場規模:容器種類別(プラスチック製単回投与容器、プラスチック製複数回投与容器、スプレー)
・OTC人工涙液の世界市場規模:製剤別(防腐剤、非防腐剤)
・OTC人工涙液の世界市場規模:用途別(ドライアイ症候群、アレルギー、感染症、紫外線・ブルーライト保護、コンタクトレンズ水分保持)
・OTC人工涙液の世界市場規模:地域別
・企業情報
【レポートの概要】

The global OTC artificial tears market generated $4,379 million in 2020, and is projected to reach $6,399.43 million by 2028, growing at a CAGR of 4.94% from 2021 to 2028.
Artificial tears also known as ocular lubricants are eye drops that are used to lubricate dry eyes and maintain moisture on the outer surface of the eye for a longer duration of time. Over-the-counter (OTC) artificial tears are the products that are available directly to the consumer without prescription.

The global OTC artificial tears market is majorly driven by rise in geriatric population; an alarming increase in the prevalence of dry eye syndrome (DES); and a rise in the number of eye surgeries which increases the demand for artificial tear drops for post-surgery management. For instance, according to the World Health Organization (WHO), in 2021, approximately 2.2 billion population in the world was reported to be diagnosed with vision impairment.

As per the data published in BioMed Central (BMC) Ophthalmology, in 2020, a total of 90% population across the globe suffered from dry eye syndrome. Moreover, the geriatric population is more vulnerable to dry eye syndrome due to inadequate tear production from lacrimal gland, altered reflex secretion or inflammatory destruction of the lacrimal glands. For instance, as per the data published by the Journal of the United Nations, 962 million population were present above the age of 60 years in 2017 which is expected to get double to nearly 2.1 billion by the year of 2050. Thus, the rise in the geriatric population and increase in prevalence of dry eye syndrome are expected to propel the demand for OTC artificial tears, which, in turn, augments the market growth. Furthermore, the increase in number of eye surgeries, upsurge the need of artificial tear drops for the post-surgical management.

Furthermore, OTC artificial tears play an important role in the global healthcare sector. Availability of different dosage forms of OTC artificial tears such as drops, ointment, emulsion, spray solution, and gel is used for providing relief from irritation, burning, and discomfort which is caused due to dry eye syndrome. Moreover, rise in investment and activities in R&D by various healthcare sectors for the development of new OTC artificial tears, such as REFRESH DIGITAL lubricant eye drop (AbbVie Inc.), drive the growth of the global market. Upsurge in technological advancement and rise in the number of people wearing contact lens, also increases the demand for OTC artificial tear and propel the growth of the market. In addition, change in the lifestyle habit such as prolong exposure to digital display and the surge in number of smartphone addicts, causes dry eye syndrome that increase the usage of artificial tears and boosts the market growth.

On the contrary, the risk of contamination associated with OTC artificial tears and adverse reaction due to presence of preservative in the formulations is anticipated to hinder the market growth during the forecast period. The adverse reactions caused due to use of artificial tear products include blurred vision, eye pain, skin rash, and redness around the eye.

The OTC artificial tears market is segmented into product type, container type, formulation, application, distribution channel and region. Depending on product type, the market is segmented into solution, ointment, emulsion, gel, spray solution and suspension. On the basis of container type, the market is fragmented into the plastic single dose container, plastic multi-dose container and spray. The plastic single dose container segment is further classified into preservative free system and preserved system. Further, the spray segment is further bifurcated into preservative free system and preserved system. On the basic of formulation, it is differentiated into preservative based and non-preservative based. By application, the global market is segregated into dry eye syndrome, allergies, infections, UV & blue light protection, contact lens moisture retention and others.

As per distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. At regional level, the OTC artificial tears market is analyzed across North America, Europe, Asia-Pacific, Middle East, North-Africa and Rest of World.
The report provides an extensive competitive analysis and profiles of the key market players such as AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd, Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.

KEY BENEFITS FOR STAKEHOLDERS
 The report provides an in-depth analysis of the global OTC artificial tears market size along with the current trends and future estimations to elucidate the imminent investment pockets.
 It offers market analysis from 2021 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
 A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
 The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global OTC artificial tears market.

KEY MARKET SEGMENTS
By Product
• Solution
• Ointment
• Emulsion
• Gel
• Spray Solution
• Suspensions

By Container Type
• Plastic Single Dose Container
• Plastic multi-dose containers
o Preservative-Free System
o Preserved System
• Spray
o Preservative-Free System
o Preserved System

By Formulation
• Preservative Based
• Non-Preservative Based

By Application
• Dry Eye Syndrome
• Allergies
• Infections
• UV & Blue Light Protection
• Contact Lens Moisture Retention
• Others

By Distribution Channel
• Hospital Pharmacies
• Drug Store & Retail Pharmacies
• Online Pharmacies

By Region
o North America
 U.S.
 Rest of North America
o Europe
 UK
 Germany
 France
 Italy
 Spain
 Poland
 Rest of Europe
o Asia-Pacific
 Japan
 China
 India
 Malaysia
 Thailand
 Philippines
 Rest of Asia-Pacific
o Middle East
 UAE
 Saudi Arabia
 Palestine
 Jordan
 Bahrain
 Qatar
 Azerbaijan
 Georgia
 Iraq
 Pakistan
 Kuwait
 Israel
 Kazakhstan
 Rest of Middle East
o North Africa
 Morocco
 Algeria
 Tunisia
 Libya
 Egypt
 Rest of North Africa
o Rest of World

KEY MARKET PLAYERS
• AbbVie, Inc.
• Akorn, Inc.
• Alcon
• Bausch and Lamb
• Johnson and Johnson
• OcuSoft
• Santen Pharmaceutical Co. Ltd
• Similasan Corporation
• Sun Pharmaceutical Industries Limited
• Ursapharm Arzneimittel GmbH

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

CHAPTER 3:MARKET LANDSCAPE

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.PORTER’S FIVE FORCES ANALYSIS

3.3.1.Bargaining power of suppliers
3.3.2.Threat of new entrants
3.3.3.Threat of substitutes
3.3.4.Competitive rivalry
3.3.5.Bargaining power among buyers

3.4.MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING 2019
3.5.MARKET DYNAMICS

3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities

3.6.IMPACT ANALYSIS OF COVID-19 ON MARKET

CHAPTER 4:OTC ARTIFICIAL TEARS MARKET BY PRODUCT TYPE

4.1.OVERVIEW
4.2.SOLUTION

4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market share analysis, by country

4.3.OINTMENT

4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country

4.4.EMULSION

4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market share analysis, by country

4.5.GEL

4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market share analysis, by country

4.6.SPRAY SOLUTION

4.6.1.Key market trends, growth factors and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market share analysis, by country

4.7.SUSPENSIONS

4.7.1.Key market trends, growth factors and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market share analysis, by country

CHAPTER 5:OTC ARTIFICIAL TEARS MARKET BY CONTAINER TYPE

5.1.OVERVIEW
5.2.PLASTIC SINGLE DOSE CONTAINER

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country

5.3.PLASTIC MULTI-DOSE CONTAINER

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country
5.3.4.Preservative-free system

5.3.4.1.Market size and forecast

5.3.5.Preserved Systems

5.3.5.1.Market size and forecast

5.4.SPRAY

5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
5.4.4.Preservative-free system

5.4.4.1.Market size and forecast

5.4.5.Preserved Systems

5.4.5.1.Market size and forecast

CHAPTER 6:OTC ARTIFICIAL TEARS MARKET BY FORMULATION

6.1.OVERVIEW
6.2.PRESERVATIVE BASED

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country

6.3.NON-PRESERVATIVE BASED

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country

CHAPTER 7:OTC ARTIFICIAL TEARS MARKET BY APPLICATION

7.1.OVERVIEW
7.2.DRY EYE SYNDROME

7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country

7.3.ALLERGIES

7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country

7.4.INFECTIONS

7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country

7.5.UV AND BLUE LIGHT PROTECTION

7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country

7.6.CONTACT LENS MOISTURE RETENTION

7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country

7.7.OTHERS

7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region
7.7.3.Market share analysis, by country

CHAPTER 8:OTC ARTIFICIAL TEARS MARKET BY DISTRIBUTION CHANNEL

8.1.OVERVIEW
8.2.HOSPITAL PHARMACIES

8.2.1.Key market trends, growth factors and opportunities
8.2.2.Market size and forecast, by region
8.2.3.Market share analysis, by country

8.3.DRUG STORE AND RETAIL PHARMACIES

8.3.1.Key market trends, growth factors and opportunities
8.3.2.Market size and forecast, by region
8.3.3.Market share analysis, by country

8.4.ONLINE PHARMACIES

8.4.1.Key market trends, growth factors and opportunities
8.4.2.Market size and forecast, by region
8.4.3.Market share analysis, by country

CHAPTER 9:OTC ARTIFICIAL TEARS MARKET BY REGION

9.1.OVERVIEW
9.2.NORTH AMERICA

9.2.1.Key market trends and opportunities
9.2.2.Market size and forecast, by product type
9.2.3.Market size and forecast, by container type
9.2.4.Market size and forecast, by formulation
9.2.5.Market size and forecast, by application
9.2.6.Market size and forecast, by distribution channel
9.2.7.Market size and forecast, by Country
9.2.8.U.S.

9.2.8.1.Market size and forecast, by product type
9.2.8.2.Market size and forecast, by container type
9.2.8.3.Market size and forecast, by formulation
9.2.8.4.Market size and forecast, by application
9.2.8.5.Market size and forecast, by distribution channel

9.2.9.Rest of North America

9.2.9.1.Market size and forecast, by product type
9.2.9.2.Market size and forecast, by container type
9.2.9.3.Market size and forecast, by formulation
9.2.9.4.Market size and forecast, by application
9.2.9.5.Market size and forecast, by distribution channel

9.3.EUROPE

9.3.1.Key market trends and opportunities
9.3.2.Market size and forecast, by product type
9.3.3.Market size and forecast, by container type
9.3.4.Market size and forecast, by formulation
9.3.5.Market size and forecast, by application
9.3.6.Market size and forecast, by distribution channel
9.3.7.Market size and forecast, by Country
9.3.8.UK

9.3.8.1.Market size and forecast, by product type
9.3.8.2.Market size and forecast, by container type
9.3.8.3.Market size and forecast, by formulation
9.3.8.4.Market size and forecast, by application
9.3.8.5.Market size and forecast, by distribution channel

9.3.9.Germany

9.3.9.1.Market size and forecast, by product type
9.3.9.2.Market size and forecast, by container type
9.3.9.3.Market size and forecast, by formulation
9.3.9.4.Market size and forecast, by application
9.3.9.5.Market size and forecast, by distribution channel

9.3.10.France

9.3.10.1.Market size and forecast, by product type
9.3.10.2.Market size and forecast, by container type
9.3.10.3.Market size and forecast, by formulation
9.3.10.4.Market size and forecast, by application
9.3.10.5.Market size and forecast, by distribution channel

9.3.11.Italy

9.3.11.1.Market size and forecast, by product type
9.3.11.2.Market size and forecast, by container type
9.3.11.3.Market size and forecast, by formulation
9.3.11.4.Market size and forecast, by application
9.3.11.5.Market size and forecast, by distribution channel

9.3.12.Spain

9.3.12.1.Market size and forecast, by product type
9.3.12.2.Market size and forecast, by container type
9.3.12.3.Market size and forecast, by formulation
9.3.12.4.Market size and forecast, by application
9.3.12.5.Market size and forecast, by distribution channel

9.3.13.Poland

9.3.13.1.Market size and forecast, by product type
9.3.13.2.Market size and forecast, by container type
9.3.13.3.Market size and forecast, by formulation
9.3.13.4.Market size and forecast, by application
9.3.13.5.Market size and forecast, by distribution channel

9.3.14.Rest of Europe

9.3.14.1.Market size and forecast, by product type
9.3.14.2.Market size and forecast, by container type
9.3.14.3.Market size and forecast, by formulation
9.3.14.4.Market size and forecast, by application
9.3.14.5.Market size and forecast, by distribution channel

9.4.ASIA-PACIFIC

9.4.1.Key market trends and opportunities
9.4.2.Market size and forecast, by product type
9.4.3.Market size and forecast, by container type
9.4.4.Market size and forecast, by formulation
9.4.5.Market size and forecast, by application
9.4.6.Market size and forecast, by distribution channel
9.4.7.Market size and forecast, by Country
9.4.8.Japan

9.4.8.1.Market size and forecast, by product type
9.4.8.2.Market size and forecast, by container type
9.4.8.3.Market size and forecast, by formulation
9.4.8.4.Market size and forecast, by application
9.4.8.5.Market size and forecast, by distribution channel

9.4.9.China

9.4.9.1.Market size and forecast, by product type
9.4.9.2.Market size and forecast, by container type
9.4.9.3.Market size and forecast, by formulation
9.4.9.4.Market size and forecast, by application
9.4.9.5.Market size and forecast, by distribution channel

9.4.10.India

9.4.10.1.Market size and forecast, by product type
9.4.10.2.Market size and forecast, by container type
9.4.10.3.Market size and forecast, by formulation
9.4.10.4.Market size and forecast, by application
9.4.10.5.Market size and forecast, by distribution channel

9.4.11.Malaysia

9.4.11.1.Market size and forecast, by product type
9.4.11.2.Market size and forecast, by container type
9.4.11.3.Market size and forecast, by formulation
9.4.11.4.Market size and forecast, by application
9.4.11.5.Market size and forecast, by distribution channel

9.4.12.Vietnam

9.4.12.1.Market size and forecast, by product type
9.4.12.2.Market size and forecast, by container type
9.4.12.3.Market size and forecast, by formulation
9.4.12.4.Market size and forecast, by application
9.4.12.5.Market size and forecast, by distribution channel

9.4.13.Thailand

9.4.13.1.Market size and forecast, by product type
9.4.13.2.Market size and forecast, by container type
9.4.13.3.Market size and forecast, by formulation
9.4.13.4.Market size and forecast, by application
9.4.13.5.Market size and forecast, by distribution channel

9.4.14.Philippines

9.4.14.1.Market size and forecast, by product type
9.4.14.2.Market size and forecast, by container type
9.4.14.3.Market size and forecast, by formulation
9.4.14.4.Market size and forecast, by application
9.4.14.5.Market size and forecast, by distribution channel

9.4.15.Rest of Asia-Pacific

9.4.15.1.Market size and forecast, by product type
9.4.15.2.Market size and forecast, by container type
9.4.15.3.Market size and forecast, by formulation
9.4.15.4.Market size and forecast, by application
9.4.15.5.Market size and forecast, by distribution channel

9.5.MIDDLE EAST

9.5.1.Key market trends and opportunities
9.5.2.Market size and forecast, by product type
9.5.3.Market size and forecast, by container type
9.5.4.Market size and forecast, by formulation
9.5.5.Market size and forecast, by application
9.5.6.Market size and forecast, by distribution channel
9.5.7.Market size and forecast, by Country
9.5.8.UAE

9.5.8.1.Market size and forecast, by product type
9.5.8.2.Market size and forecast, by container type
9.5.8.3.Market size and forecast, by formulation
9.5.8.4.Market size and forecast, by application
9.5.8.5.Market size and forecast, by distribution channel

9.5.9.Saudi Arabia

9.5.9.1.Market size and forecast, by product type
9.5.9.2.Market size and forecast, by container type
9.5.9.3.Market size and forecast, by formulation
9.5.9.4.Market size and forecast, by application
9.5.9.5.Market size and forecast, by distribution channel

9.5.10.Palestine

9.5.10.1.Market size and forecast, by product type
9.5.10.2.Market size and forecast, by container type
9.5.10.3.Market size and forecast, by formulation
9.5.10.4.Market size and forecast, by application
9.5.10.5.Market size and forecast, by distribution channel

9.5.11.Jordan

9.5.11.1.Market size and forecast, by product type
9.5.11.2.Market size and forecast, by container type
9.5.11.3.Market size and forecast, by formulation
9.5.11.4.Market size and forecast, by application
9.5.11.5.Market size and forecast, by distribution channel

9.5.12.Bahrein

9.5.12.1.Market size and forecast, by product type
9.5.12.2.Market size and forecast, by container type
9.5.12.3.Market size and forecast, by formulation
9.5.12.4.Market size and forecast, by application
9.5.12.5.Market size and forecast, by distribution channel

9.5.13.Qatar

9.5.13.1.Market size and forecast, by product type
9.5.13.2.Market size and forecast, by container type
9.5.13.3.Market size and forecast, by formulation
9.5.13.4.Market size and forecast, by application
9.5.13.5.Market size and forecast, by distribution channel

9.5.14.Azerbaijan

9.5.14.1.Market size and forecast, by product type
9.5.14.2.Market size and forecast, by container type
9.5.14.3.Market size and forecast, by formulation
9.5.14.4.Market size and forecast, by application
9.5.14.5.Market size and forecast, by distribution channel

9.5.15.Georgia

9.5.15.1.Market size and forecast, by product type
9.5.15.2.Market size and forecast, by container type
9.5.15.3.Market size and forecast, by formulation
9.5.15.4.Market size and forecast, by application
9.5.15.5.Market size and forecast, by distribution channel

9.5.16.Iraq

9.5.16.1.Market size and forecast, by product type
9.5.16.2.Market size and forecast, by container type
9.5.16.3.Market size and forecast, by formulation
9.5.16.4.Market size and forecast, by application
9.5.16.5.Market size and forecast, by distribution channel

9.5.17.Pakistan

9.5.17.1.Market size and forecast, by product type
9.5.17.2.Market size and forecast, by container type
9.5.17.3.Market size and forecast, by formulation
9.5.17.4.Market size and forecast, by application
9.5.17.5.Market size and forecast, by distribution channel

9.5.18.Kuwait

9.5.18.1.Market size and forecast, by product type
9.5.18.2.Market size and forecast, by container type
9.5.18.3.Market size and forecast, by formulation
9.5.18.4.Market size and forecast, by application
9.5.18.5.Market size and forecast, by distribution channel

9.5.19.Israel

9.5.19.1.Market size and forecast, by product type
9.5.19.2.Market size and forecast, by container type
9.5.19.3.Market size and forecast, by formulation
9.5.19.4.Market size and forecast, by application
9.5.19.5.Market size and forecast, by distribution channel

9.5.20.Kazakhstan

9.5.20.1.Market size and forecast, by product type
9.5.20.2.Market size and forecast, by container type
9.5.20.3.Market size and forecast, by formulation
9.5.20.4.Market size and forecast, by application
9.5.20.5.Market size and forecast, by distribution channel

9.5.21.Rest of Middle East

9.5.21.1.Market size and forecast, by product type
9.5.21.2.Market size and forecast, by container type
9.5.21.3.Market size and forecast, by formulation
9.5.21.4.Market size and forecast, by application
9.5.21.5.Market size and forecast, by distribution channel

9.6.NORTH AFRICA

9.6.1.Key market trends and opportunities
9.6.2.Market size and forecast, by product type
9.6.3.Market size and forecast, by container type
9.6.4.Market size and forecast, by formulation
9.6.5.Market size and forecast, by application
9.6.6.Market size and forecast, by distribution channel
9.6.7.Market size and forecast, by Country
9.6.8.Morocco

9.6.8.1.Market size and forecast, by product type
9.6.8.2.Market size and forecast, by container type
9.6.8.3.Market size and forecast, by formulation
9.6.8.4.Market size and forecast, by application
9.6.8.5.Market size and forecast, by distribution channel

9.6.9.Algeria

9.6.9.1.Market size and forecast, by product type
9.6.9.2.Market size and forecast, by container type
9.6.9.3.Market size and forecast, by formulation
9.6.9.4.Market size and forecast, by application
9.6.9.5.Market size and forecast, by distribution channel

9.6.10.Tunisia

9.6.10.1.Market size and forecast, by product type
9.6.10.2.Market size and forecast, by container type
9.6.10.3.Market size and forecast, by formulation
9.6.10.4.Market size and forecast, by application
9.6.10.5.Market size and forecast, by distribution channel

9.6.11.Libia

9.6.11.1.Market size and forecast, by product type
9.6.11.2.Market size and forecast, by container type
9.6.11.3.Market size and forecast, by formulation
9.6.11.4.Market size and forecast, by application
9.6.11.5.Market size and forecast, by distribution channel

9.6.12.Egypt

9.6.12.1.Market size and forecast, by product type
9.6.12.2.Market size and forecast, by container type
9.6.12.3.Market size and forecast, by formulation
9.6.12.4.Market size and forecast, by application
9.6.12.5.Market size and forecast, by distribution channel

9.6.13.Rest of North Africa

9.6.13.1.Market size and forecast, by product type
9.6.13.2.Market size and forecast, by container type
9.6.13.3.Market size and forecast, by formulation
9.6.13.4.Market size and forecast, by application
9.6.13.5.Market size and forecast, by distribution channel

CHAPTER 10:COMPANY PROFILES

10.1.SANTEN PHARMACEUTICAL

10.1.1.Company overview
10.1.2.Key Executives
10.1.3.Company snapshot
10.1.4.Operating business segments
10.1.5.Product portfolio
10.1.6.Business performance
10.1.7.Key strategic moves and developments

10.2.BAUSCH & LOMB

10.2.1.Company overview
10.2.2.Key Executives
10.2.3.Company snapshot
10.2.4.Operating business segments
10.2.5.Product portfolio
10.2.6.Business performance
10.2.7.Key strategic moves and developments

10.3.ALLERGAN

10.3.1.Company overview
10.3.2.Key Executives
10.3.3.Company snapshot
10.3.4.Operating business segments
10.3.5.Product portfolio
10.3.6.Business performance
10.3.7.Key strategic moves and developments

10.4.ABBOTT LABORATORIES

10.4.1.Company overview
10.4.2.Key Executives
10.4.3.Company snapshot
10.4.4.Operating business segments
10.4.5.Product portfolio
10.4.6.Business performance
10.4.7.Key strategic moves and developments

10.5.JOHNSON & JOHNSON

10.5.1.Company overview
10.5.2.Key Executives
10.5.3.Company snapshot
10.5.4.Operating business segments
10.5.5.Product portfolio
10.5.6.Business performance
10.5.7.Key strategic moves and developments

10.6.LUMECARE

10.6.1.Company overview
10.6.2.Key Executives
10.6.3.Company snapshot
10.6.4.Operating business segments
10.6.5.Product portfolio
10.6.6.Business performance
10.6.7.Key strategic moves and developments

10.7.SIMILASAN CORPORATION

10.7.1.Company overview
10.7.2.Key Executives
10.7.3.Company snapshot
10.7.4.Operating business segments
10.7.5.Product portfolio
10.7.6.Business performance
10.7.7.Key strategic moves and developments

10.8.URSAPHARM

10.8.1.Company overview
10.8.2.Key Executives
10.8.3.Company snapshot
10.8.4.Operating business segments
10.8.5.Product portfolio
10.8.6.Business performance
10.8.7.Key strategic moves and developments

10.9.NOVARTIS AG (ALCON)

10.9.1.Company overview
10.9.2.Key Executives
10.9.3.Company snapshot
10.9.4.Operating business segments
10.9.5.Product portfolio
10.9.6.Business performance
10.9.7.Key strategic moves and developments

10.10.OCUSOFT

10.10.1.Company overview
10.10.2.Key Executives
10.10.3.Company snapshot
10.10.4.Operating business segments
10.10.5.Product portfolio
10.10.6.Business performance
10.10.7.Key strategic moves and developments

LIST OF TABLES

TABLE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 2.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, BY REGION, 2019-2027 ($MILLION)
TABLE 3.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, BY REGION, 2019-2027 ($MILLION)
TABLE 4.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, BY REGION, 2019-2027 ($MILLION)
TABLE 5.OTC ARTIFICIAL TEARS MARKET FOR GEL, BY REGION, 2019-2027 ($MILLION)
TABLE 6.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, BY REGION, 2019-2027 ($MILLION)
TABLE 7.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, BY REGION, 2019-2027 ($MILLION)
TABLE 8.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 9.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
TABLE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
TABLE 11.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 12.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
TABLE 13.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, BY REGION, 2019-2027 ($MILLION)
TABLE 14.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 15.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
TABLE 16.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION 2019-2027 ($MILLION)
TABLE 17.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
TABLE 18.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
TABLE 19.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION 2019-2027 ($MILLION)
TABLE 20.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, BY REGION, 2019-2027 ($MILLION)
TABLE 21.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, BY REGION, 2019-2027 ($MILLION)
TABLE 22.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, BY REGION, 2019-2027 ($MILLION)
TABLE 23.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, BY REGION, 2019-2027 ($MILLION)
TABLE 24.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, BY REGION, 2019-2027 ($MILLION)
TABLE 25.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
TABLE 26.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 27.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 28.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 29.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 30.OTC ARTIFICIAL TEARS MARKET FOR , BY REGION, , 2019-2027 ($MILLION)
TABLE 31.NORTH AMERICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 33.NORTH AMERICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 34.NORTH AMERICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 35.NORTH AMERICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 36.NORTH AMERICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 37.EUROPE OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 38.EUROPE OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 39.EUROPE OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 40.EUROPE OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 41.EUROPE OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 42.EUROPE OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 43.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 44.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 45.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 46.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 47.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 48.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 49.MIDDLE EAST OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 50.MIDDLE EAST OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 51.MIDDLE EAST OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 52.MIDDLE EAST OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 53.MIDDLE EAST OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 54.MIDDLE EAST OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 55.NORTH AFRICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 56.NORTH AFRICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 57.NORTH AFRICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 58.NORTH AFRICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 59.NORTH AFRICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 60.NORTH AFRICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 61.SANTEN PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 62.SANTEN PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 63.BAUSCH & LOMB: COMPANY SNAPSHOT
TABLE 64.BAUSCH & LOMB: OPERATING SEGMENTS
TABLE 65.ALLERGAN: COMPANY SNAPSHOT
TABLE 66.ALLERGAN: OPERATING SEGMENTS
TABLE 67.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 68.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 69.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 70.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 71.LUMECARE: COMPANY SNAPSHOT
TABLE 72.LUMECARE: OPERATING SEGMENTS
TABLE 73.SIMILASAN CORPORATION: COMPANY SNAPSHOT
TABLE 74.SIMILASAN CORPORATION: OPERATING SEGMENTS
TABLE 75.URSAPHARM: COMPANY SNAPSHOT
TABLE 76.URSAPHARM: OPERATING SEGMENTS
TABLE 77.NOVARTIS AG (ALCON): COMPANY SNAPSHOT
TABLE 78.NOVARTIS AG (ALCON): OPERATING SEGMENTS
TABLE 79.OCUSOFT: COMPANY SNAPSHOT
TABLE 80.OCUSOFT: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET SEGMENTATION
FIGURE 2.TOP INVESTMENT POCKET
FIGURE 3.TOP WINNING STRATEGIES (%)
FIGURE 4.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, 2019-2027 ($MILLION)
FIGURE 5.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, 2019-2027 ($MILLION)
FIGURE 6.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, 2019-2027 ($MILLION)
FIGURE 7.OTC ARTIFICIAL TEARS MARKET FOR GEL, 2019-2027 ($MILLION)
FIGURE 8.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, 2019-2027 ($MILLION)
FIGURE 9.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, 2019-2027 ($MILLION)
FIGURE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, 2019-2027 ($MILLION)
FIGURE 11.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, 2019-2027 ($MILLION)
FIGURE 12.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, 2019-2027 ($MILLION)
FIGURE 13.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, 2019-2027 ($MILLION)
FIGURE 14.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, 2019-2027 ($MILLION)
FIGURE 15.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, 2019-2027 ($MILLION)
FIGURE 16.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, 2019-2027 ($MILLION)
FIGURE 17.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, 2019-2027 ($MILLION)
FIGURE 18.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, 2019-2027 ($MILLION)
FIGURE 19.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, 2019-2027 ($MILLION)
FIGURE 20.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 21.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, 2019-2027 ($MILLION)
FIGURE 22.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, 2019-2027 ($MILLION)
FIGURE 23.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, 2019-2027 ($MILLION)
FIGURE 24.GLOBAL OTC ARTIFICIAL TEARS, BY REGION, 2019 (%)
FIGURE 25.U.S. OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 26.REST OF NORTH AMERICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 27.UK OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 28.GERMANY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 29.FRANCE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 30.ITALY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 31.SPAIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 32.POLAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 33.REST OF EUROPE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 34.JAPAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 35.CHINA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 36.INDIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 37.MALAYSIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 38.VIETNAM OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 39.THAILAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 40.PHILIPPINES OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 41.REST OF ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 42.UAE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 43.SAUDI ARABIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 44.PALESTINE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 45.JORDAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 46.BAHREIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 47.QATAR OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 48.AZERBAIJAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 49.GEORGIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 50.IRAQ OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 51.PAKISTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 52.KUWAIT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 53.ISRAEL OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 54.KAZAKHSTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 55.REST OF MIDDLE EAST OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 56.MOROCCO OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 57.ALGERIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 58.TUNISIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 59.LIBIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 60.EGYPT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 61.REST OF NORTH AFRICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[OTC人工涙液の世界市場2021年-2028年:製品種類別(溶液、軟膏、乳剤、ゲル、スプレー溶液、懸濁液)、容器種類別、製剤別、用途別、流通チャネル別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆